Progesterone Receptor-positive Breast Cancer
📧 Sign up to get email alerts when something new happens for Progesterone Receptor-positive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer [Phase 2]
Phase 2 clinical trial updates show BRC-001, a cannabidiol plant extract, being studied to improve aromatase inhibitor-induced arthralgia in…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer [Phase 1]
This clinical trial update reports testing the addition of berzosertib to radiation therapy in patients with chemotherapy-resistant triple-n…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers [Phase 2]
Phase 2 clinical trial evaluating pre-operative Neratinib and Trastuzumab with endocrine therapy for ER-positive, HER2-positive breast cance…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
A Mayo Clinic-sponsored trial is evaluating interventions to improve skin appearance and quality of life for breast cancer survivors on arom…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis [Phase 2]
A Phase 2 clinical trial evaluating the combination of radiation therapy, palbociclib, and endocrine (hormone) therapy in patients with estr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating BYL719 (alpelisib) with letrozole in post-menopausal women with hormone receptor-positive metastatic breas…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca [Phase 2]
Phase 2 trial evaluating neoadjuvant pembrolizumab plus decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2-n…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Phase II Study of Everolimus Beyond Progression [Phase 2]
Phase II trial evaluating Everolimus beyond progression in breast cancer was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus [Phase 2]
Phase 2 clinical trial evaluating a mucoadhesive oral wound rinse to prevent and treat stomatitis in patients with ER- or PR-positive metast…
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid [NA]
A terminated clinical trial investigating biomarkers in tissue samples from newly diagnosed breast cancer patients treated with zoledronic a…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery [Phase 2]
A Phase 2 trial evaluating pre-surgery chemotherapy with filgrastim in patients with HER2-positive breast cancer that could be surgically re…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer [Phase 2]
Phase 2 trial of hormone therapy and combination chemotherapy before and after surgery for stage I-IIIA breast cancer was terminated; result…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms [Phase 2]
Phase 2 clinical trial evaluating zoledronic acid for aromatase inhibitor-induced musculoskeletal symptoms in breast cancer patients has com…
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) [Phase 2]
Phase II study evaluating androgen receptor–targeted therapy in pre-treated postmenopausal patients with ER/PR status and AR positivity in m…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer [Phase 3]
A Phase 3 trial assessed ovarian function suppression with tamoxifen or exemestane versus tamoxifen alone in premenopausal women with hormon…
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer [Phase 2]
Open-label Phase 2 window-of-opportunity study evaluating ganetespib in women with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-25Clinical Trial Update: F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating F-18 16 alpha-fluoroestradiol PET to predict response to first-line hormone therapy in patients with stage…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer [Phase 1]
Phase 1 trial evaluating RO4929097 in combination with letrozole for postmenopausal women with estrogen receptor-positive, HER2-negative bre…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer [Phase 2]
A Phase 2 study comparing anastrozole plus gefitinib to fulvestrant plus gefitinib in postmenopausal women with metastatic breast cancer; re…